Identification of 14,2

Journal of Biochemistry

Volumn 156, Issue 6, 2014, Pages 315-321

  Yokokura, Yoshiyuki ^a   Isobe, Yosuke ^a,b   Matsueda, Shinnosuke ^a   Iwamoto, Ryo ^a   Goto, Tomomi ^a   Yoshioka, Takeshi ^a   Urabe, Daisuke ^a   Inoue, Masayuki ^a   Arai, Hiroyuki ^a   Arita, Makoto ^a,b,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b Institute of Physical and Chemical Research   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

15 lipoxygenase; anti inflammation; lipidomics 12; omega 3 polyunsaturated fatty acid

Indexed keywords

14,20 DIHYDROXY DOCOSAHEXAENOIC ACID; ANTIINFLAMMATORY AGENT; DOCOSAHEXAENOIC ACID; UNCLASSIFIED DRUG; 14,20-DIHYDROXY-DOCOSAHEXAENOIC ACID; LIPID; NONSTEROID ANTIINFLAMMATORY AGENT; ZYMOSAN;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ISOLATION; DRUG IDENTIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; EOSINOPHIL; LEUKOCYTE; LIQUID CHROMATOGRAPHY; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; STEREOISOMERISM; TANDEM MASS SPECTROMETRY; ZYMOSAN-INDUCED PERITONITIS; ANIMAL; CHEMISTRY; IMMUNOLOGY; MASS SPECTROMETRY; METABOLISM; NEUTROPHIL CHEMOTAXIS; PERITONITIS; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHROMATOGRAPHY, LIQUID; DOCOSAHEXAENOIC ACIDS; EOSINOPHILS; LIPIDS; MASS SPECTROMETRY; MICE; NEUTROPHIL INFILTRATION; PERITONITIS; STEREOISOMERISM; ZYMOSAN;

EID: 84922464551     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvu044     Document Type: Article

References (28)

1. De Caterina, R.; Endres, S.; Kristensen, S.D.; and Schmidt, E.B. (1993) N-3 Fatty Acids and Vascular Disease. Bi & Gi Publishers, Verona. p. 166
2. Simopoulos, A.P. (2002) Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr. 21, 495-505
3. McGahon, B.M.; Martin, D.S.; Horrobin, D.F.; and Lynch, M.A. (1999) Age-related changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids. Neuroscience 94, 305-314
4. Kim, H.Y.; Akbar, M.; Lau, A.; and Edsall, L. (2000) Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3): role of phosphatidylserine in antiaptotic effect. J. Biol. Chem. 275, 35215-35223
5. McLennan, P.; Howe, P.; Abeywardena, M.; Muggli, R.; Raederstorff, D.; Mano, M.; Rayner, T.; and Head, R. (1996) The cardiovascular protective role of docosahexaenoic acid. Eur. J. Pharmacol. 300, 83-89
6. Guillot, N.; Caillet, E.; Laville, M.; Calzada, C.; Lagarde, M.; and Vericel, E. (2009) Increasing intakes of the long-chain o-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men. FASEB J. 23, 2909-2916
7. Corey, E.J.; Shih, C.; and Cashman, J.R. (1983) Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc. Natl Acad. Sci. USA 80, 3581-3584
8. Shikano, M.; Masuzawa, Y.; Yazawa, K.; Takayama, K.; Kudo, I.; and Inoue, K. (1994) Complete discrimination of docosahexaenoate from arachidonate by 85 kDa cytosolic phospholipase A2 during the hydrolysis of diacyl-and alkenylacylglycerophosphoethanolamines. Biochim. Biophys. Acta 1212, 211-216
9. Serhan, C.N.; Hong, S.; Gronert, K.; Colgan, S.P.; Devchand, P.R.; Mirick, G.; and Moussignac, R.L. (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits Initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025-1037
10. Hong, S.; Gronert, K.; Devchand, P.R.; Moussignac, R.L.; and Serhan, C.N. (2003) Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. J. Biol. Chem. 278, 14677-14687
11. Bannenberg, G. and Serhan, C.N. (2010) Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochim. Biophys. Acta 1801, 1260-1273
12. Mukherjee, P.K.; Marcheselli, V.L.; Serhan, C.N.; and Bazan, N.G. (2004) Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl Acad. Sci. USA 101, 8491-8496
13. Marcheselli, V.L.; Hong, S.; Lukiw, W.J.; Tian, X.H.; Groner, K.; Musto, A.; Hardy, M.; Gimenez, J.M.; Chiang, N.; Serhan, C.N.; and Bazan, N.G. (2003) Novel docosanoids inhibit brain ischemia-reperfusionmediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278, 43807-43817
14. Gronert, K.; Maheshwari, N.; Khan, N.; Hassan, I.R.; Dunn, M.; and Schwartzman, M.L. (2005) A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J. Biol. Chem. 280, 15267-15278
15. Schwab, J.M.; Chiang, N.; Arita, M.; and Serhan, C.N. (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447, 869-874
16. Duffield, J.S.; Hong, S.; Vaidya, V.S.; Lu, Y.; Fredman, G.; Serhan, C.N.; and Bonventre, J.V. (2006) Resolvin D series and Protectin D1 mitigate acute kidney injury. J. Immunol. 177, 5902-5911
17. Spite, M.; Norling, L.V.; Summers, L.; Yang, R.; Dianne, C.; Petasis, N.A.; Flower, R.J.; Perretti, M.; and Serhan, C.N. (2009) Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461, 1287-1292
18. Chiang, N.; Fredman, G.; Backhed, F.; Oh, S.F.; Vickery, T.; Schmidt, B.A.; and Serhan, C.N. (2012) Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484, 524-528
19. Serhan, C.N.; Yang, R.; Martinod, K.; Kasuga, K.; Pillai, P.S.; Porter, T.F.; Oh, S.F.; and Spite, M. (2008) Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J. Exp. Med. 206, 15-23
20. Lu, Y.; Tian, H.; and Hong, S. (2010) Novel 14,21-dihydroxy-docosahexaenoic acids: structures, formation pathways, and enhancement of wound healing. J. Lipid Res. 51, 923-932
21. Tominaga, A.; Takaki, S.; Koyama, N.; Katoh, S.; Matsumoto, R.; Migita, M.; Hitoshi, Y.; Hosoya, Y.; Yamauchi, S.; Kanai, Y.; Miyazaki, J.; Usuku, G.; Yamamura, K.; and Takatsu, K. (1991) Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J. Exp. Med. 173, 429-437
22. Isobe, Y.; Arita, M.; Matsueda, S.; Iwamoto, R.; Fujihara, T.; Nakanishi, H.; Taguchi, R.; Masuda, K.; Sasaki, K.; Urabe, D.; Inoue, M.; and Arai, H. (2012) Identification and structure determination of novel antiinflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid. J. Biol. Chem. 287, 10525-10534
23. Arita, M. (2012) Mediator lipidomics in acute inflammation and resolution. J. Biochem. 152, 313-319
24. Yamada, T.; Tani, Y.; Nakanishi, H.; Taguchi, R.; Arita, M.; and Arai, H. (2011) Eosinophils promote resolution of acute peritonitis producing proresolving mediators in mice. FASEB J. 25, 561-568
25. Serhan, C.N. (2007) Resolution phase of inflammation. Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25, 101-137
26. Kuhn, H. and ODonnell, V.B. (2006) Inflammation and immune regulation by 12/15-lipoxygenases. Prog. Lipid Res. 45, 334-356
27. Merched, A.J.; Ko, K.; Gotlinger, K.H.; Serhan, C.N.; and Chan, L. (2008) Atherosclerosis. Evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J. 22, 3595-3606
28. Kronke, G.; Katzenbeisser, J.; Uderhardt, S.; Zaiss, M.M.; Scholtysek, C.; Schabbauer, G.; Zarbock, A.; Koenders, M.I.; Axmann, R.; Zwerina, J.; Baenckler, H.W.; van den Berg, W.; Voll, R.E.; Kuhn, H.; Joosten, L.A.; and Schett, G. (2009) 12/15-Lipoxygenase counteracts inflammation and tissue damage in arthritis. J. Immunol. 183, 3383-3389